Skip to content

Trifecta-Kidney cfDNA-MMDx Study

Kidney Transplant Rejection

Demonstrate the relationship between DD-cfDNA levels and HLA antibodies in blood, and the Molecular Microscope® (MMDx) Diagnostic System results in indication biopsies.

null

Conditions de participation

  • Sexe:

    ALL

  • Âges admissibles:

    0 and up

Critères de participation

Inclusion Criteria:

* All kidney transplant recipients undergoing a kidney biopsy for clinical indications, as determined by their physician or surgeon, will be eligible to enroll in the study.

Exclusion Criteria:

* Patients will be excluded from the study if they decline participation or are unable to give informed consent or multiple organ recipients.

Lieu de l'étude

ST. Paul's Hospital, 6A Providence Building, 1081 Burrard Street
ST. Paul's Hospital, 6A Providence Building, 1081 Burrard Street
Vancouver, British Columbia
Canada

Contactez l'équipe d'étude

Primary Contact

Angela Ogniben

[email protected]
University of Alberta, Department of Medicine
University of Alberta, Department of Medicine
Edmonton, Alberta
Canada

Contactez l'équipe d'étude

Primary Contact

Soroush Shojai, MD

[email protected]
Étude parrainée par
University of Alberta
Participants recherchés
Plus d'informations
ID de l'étude: NCT04239703